Participant flow30

How many started, completed or left each group, period by period.

21 to 30 of 30

Period	Milestone	Group	Participants
Double-Blind Extension Period	COMPLETED	Placebo (Double-Blind Placebo-Controlled Period)	0
Double-Blind Extension Period	COMPLETED	MT-5199 40 mg (Double-Blind Placebo-Controlled Period)	0
Double-Blind Extension Period	COMPLETED	MT-5199 80 mg (Double-Blind Placebo-Controlled Period)	0
Double-Blind Extension Period	COMPLETED	MT-5199 40 mg (Double-Blind Extension Period)	67
Double-Blind Extension Period	COMPLETED	MT-5199 80 mg (Double-Blind Extension Period)	50
Double-Blind Extension Period	NOT COMPLETED	Placebo (Double-Blind Placebo-Controlled Period)	0
Double-Blind Extension Period	NOT COMPLETED	MT-5199 40 mg (Double-Blind Placebo-Controlled Period)	0
Double-Blind Extension Period	NOT COMPLETED	MT-5199 80 mg (Double-Blind Placebo-Controlled Period)	0
Double-Blind Extension Period	NOT COMPLETED	MT-5199 40 mg (Double-Blind Extension Period)	45
Double-Blind Extension Period	NOT COMPLETED	MT-5199 80 mg (Double-Blind Extension Period)	49

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03176771/flow?page=2